BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Feng X, Yang S, Zhou S, Deng S, Xie Y. Long non-coding RNA DDX11-AS1 promotes non-small cell lung cancer development via regulating PI3K/AKT signalling. Clin Exp Pharmacol Physiol 2020;47:1622-31. [PMID: 32298476 DOI: 10.1111/1440-1681.13325] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Yang X, Gao S, Wen M, Yu Q. DDX11-AS1 modulates DNA damage repair to enhance paclitaxel resistance of lung adenocarcinoma cells. Pharmacogenomics 2023;24:163-72. [PMID: 36779347 DOI: 10.2217/pgs-2022-0121] [Reference Citation Analysis]
2 Andonegui-elguera MA, Cáceres-gutiérrez RE, Oliva-rico D, Díaz-chávez J, Herrera LA. LncRNAs-associated to genomic instability: A barrier to cancer therapy effectiveness. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.984329] [Reference Citation Analysis]
3 Xiang Z, Lv Q, Zhang Y, Chen X, Guo R, Liu S, Peng X. Long non-coding RNA DDX11-AS1 promotes the proliferation and migration of glioma cells by combining with HNRNPC. Mol Ther Nucleic Acids 2022;28:601-12. [PMID: 35614994 DOI: 10.1016/j.omtn.2022.04.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Cao P, Li F, Xiao Y, Hu S, Kong K, Han P, Yue J, Deng Y, Zhao Z, Wu D, Zhang L, Zhao B, Zhang Y. Identification and Validation of 7-lncRNA Signature of Epigenetic Disorders by Comprehensive Epigenetic Analysis. Disease Markers 2022;2022:1-14. [DOI: 10.1155/2022/5118444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li Y, Wang Y, Wang X, Jin L, Yang L, Zhu J, Wang H, Zheng F, Cui H, Li X, Jia Y. Evodiamine suppresses the progression of non-small cell lung carcinoma via endoplasmic reticulum stress-mediated apoptosis pathway in vivo and in vitro. Int J Immunopathol Pharmacol 2022;36:3946320221086079. [PMID: 35388733 DOI: 10.1177/03946320221086079] [Reference Citation Analysis]
6 Guo Y, Sun P, Guo W, Yin Q, Han J, Sheng S, Liang J, Dong Z. LncRNA DDX11 antisense RNA 1 promotes EMT process of esophageal squamous cell carcinoma by sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and Wnt/β-catenin pathway. Bioengineered 2021;12:11425-40. [PMID: 34866524 DOI: 10.1080/21655979.2021.2008759] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
7 Yuan C, Yuan H, Chen L, Sheng M, Tang W. A novel three-long noncoding RNA risk score system for the prognostic prediction of triple-negative breast cancer. Biomark Med 2021;15:43-55. [PMID: 33427499 DOI: 10.2217/bmm-2020-0505] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Dai J, Wang B, Zhao Y, Zuo X, Cui H, Chen X, Liu X. Long Noncoding RNA LINC01426 Sequesters microRNA-519d-5p to Promote Non-Small Cell Lung Cancer Progression by Increasing ETS1 Expression. Cancer Manag Res 2020;12:12697-708. [PMID: 33335425 DOI: 10.2147/CMAR.S277113] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
9 Feng Y, Wu M, Hu S, Peng X, Chen F. LncRNA DDX11-AS1: a novel oncogene in human cancer. Hum Cell 2020;33:946-53. [PMID: 32772230 DOI: 10.1007/s13577-020-00409-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]